Relement

Relement is a spin‑off from TNO / Biorizon, specializing in converting non‑food biomass residues into high‑quality, bio‑based aromatic chemical building blocks.

Their first product — “bio‑MPA” (3‑methylphthalic anhydride) — is designed to replace fossil‑derived aromatics in coatings, adhesives, insulation foams, and other materials, offering improved performance (e.g. scratch resistance, durability) while reducing environmental impact. By producing bio-aromatics at scale, they aim to help shift the chemical industry away from fossil feedstocks toward more sustainable, renewable raw materials.

Our news

9 April, 2026

819 Capital Partners invests in Wolk

Deventer, 9 April 2026 - Dutch company Wolk has raised €1.75 million to accelerate the deployment of its smart hip airbag in elderly care. The investment round was led by 819 Capital Partners, through 819 Seed Fund I, and the Innovatiefonds Ouderenzorg of CbusineZ (CZ), with participation from Nivogé, Catalyst Impact Investment Club, and several angel investors. Each year in the Netherlands, approximately 120,000 elderly people end up in the emergency department after a fall....

Continue reading
6 March, 2026

819 Capital Partners acquires key assets of Lead Pharma, enabling continuation of operations

Deventer, 6 March 2026 - 819 Capital Partners has acquired the key assets of Lead Pharma, thereby realizing a continuation based on the company’s patent portfolio and associated research programs. The transaction includes intellectual property rights, research data, and selected development programs. Lead Pharma develops innovative small-molecule medicines for the treatment of cancer and autoimmune diseases. Over the past years, the company built a strong research platform and multiple drug candidates, collaborating with international pharmaceutical companies...

Continue reading